Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
1.65
Nov 20 • 3:59 PM ET Dollar change-0.20 Percentage change(-10.81%)
Aftermarket Close
1.40
Aftermarket • 7:49 PM ET Dollar change-0.25 Percentage change(-15.15%)
Nov 20, 7:32 PMWarrant-resale S-1 and special-meeting 8-K sink BIAF 22% after hours
Index
-
Market Cap
3.00M
Enterprise Value
1.95M
Income
-15.41M
Sales
5.53M
Book/sh
3.36
Cash/sh
1.40
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
57
IPO
Sep 01, 2022
P/E
-
Forward P/E
-
PEG
-
P/S
0.54
P/B
0.49
P/C
1.18
P/FCF
-
EV/EBITDA
-
EV/Sales
0.35
Quick Ratio
1.47
Current Ratio
1.51
Debt/Eq
0.38
LT Debt/Eq
0.28
Option/Short
No / Yes
EPS (ttm)
-38.13
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
45.79% 21.77%
Sales past 3/5Y
986.60% -
EPS Y/Y TTM
87.82%
Sales Y/Y TTM
-18.47%
EPS Q/Q
91.71%
Sales Q/Q
-25.99%
Insider Own
0.82%
Insider Trans
-61.61%
Inst Own
9.69%
Inst Trans
3.88%
ROA
-161.37%
ROE
-240.48%
ROIC
-306.97%
Gross Margin
20.41%
Oper. Margin
-246.14%
Profit Margin
-278.93%
SMA20
-34.64%
SMA50
-63.43%
SMA200
-90.86%
Trades
Shs Outstand
1.82M
Shs Float
1.81M
52W High
80.70 -97.96%
52W Low
1.84 -10.33%
Volatility
12.45% 11.66%
ATR (14)
0.43
RSI (14)
29.54
Beta
-0.68
Rel Volume
0.02
Avg Volume
3.50M
Volume
71,807
Perf Week
-25.00%
Perf Month
-47.95%
Perf Quarter
-71.65%
Perf Half Y
-92.95%
Perf YTD
-90.68%
Perf Year
-92.03%
Perf 3Y
-99.75%
Perf 5Y
-
Perf 10Y
-
Prev Close
1.85
Price
1.65
Change %
-10.81%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HRT FINANCIAL LP10% OwnerSep 24 '26Buy7.6730,065230,538131,221Nov 19 04:30 PM
HRT FINANCIAL LP10% OwnerSep 22 '26Buy8.5918,929162,560126,519Nov 19 04:30 PM
HRT FINANCIAL LP10% OwnerSep 29 '26Buy7.0222,734159,604134,741Nov 19 04:30 PM
HRT FINANCIAL LP10% OwnerSep 23 '26Buy8.0518,511149,012128,884Nov 19 04:30 PM
HRT FINANCIAL LP10% OwnerOct 01 '26Buy6.5417,873116,954116,658Nov 19 04:30 PM
HRT FINANCIAL LP10% OwnerSep 30 '26Buy6.7812,12582,177126,146Nov 19 04:30 PM
HRT FINANCIAL LP10% OwnerSep 28 '26Buy7.6410,73682,065127,533Nov 19 04:30 PM
HRT FINANCIAL LP10% OwnerSep 25 '26Buy7.817,27156,761126,037Nov 19 04:30 PM
HRT FINANCIAL LP10% OwnerOct 01 '26Sale6.4541,529267,721116,658Nov 19 04:30 PM
HRT FINANCIAL LP10% OwnerSep 24 '26Sale7.7527,246211,293131,221Nov 19 04:30 PM
HRT FINANCIAL LP10% OwnerSep 23 '26Sale8.0221,988176,401128,884Nov 19 04:30 PM
HRT FINANCIAL LP10% OwnerSep 29 '26Sale6.8520,828142,667134,741Nov 19 04:30 PM
HRT FINANCIAL LP10% OwnerSep 30 '26Sale6.7620,432138,198126,146Nov 19 04:30 PM
HRT FINANCIAL LP10% OwnerSep 28 '26Sale7.5714,008106,088127,533Nov 19 04:30 PM
HRT FINANCIAL LP10% OwnerSep 25 '26Sale7.869,11171,602126,037Nov 19 04:30 PM
HRT FINANCIAL LP10% OwnerSep 22 '26Sale8.637,07761,079126,519Nov 19 04:30 PM
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.
Founder & Executive Chairman of the BoardMr. Steven Girgenti
FounderMs. Maria Zannes J.D.
M.B.A.Mr. James Michael Edwards CPA
Chief Operating OfficerMr. Xavier T. Reveles M.S.
Chief Science OfficerDr. William Bauta Ph.D.